Efficacy and safety of sodium zirconium cyclosilicate in patients with baseline serum potassium level ≥ 5.5 mmol/L: pooled analysis from two phase 3 trials

摘要

Baseline demographics and characteristics of patients with baseline serum K  ≥ 5.5 mmol/L